Pharmacokinetics, efficacy and safety of daclatasvir plus asunaprevir in dialysis patients with chronic hepatitis C: pilot study.

Kawakami, Y

Pharmacokinetics, efficacy and safety of daclatasvir plus asunaprevir in dialysis patients with chronic hepatitis C: pilot study. [electronic resource] - Journal of viral hepatitis 11 2016 - 850-856 p. digital

Publication Type: Journal Article; Multicenter Study

1365-2893

10.1111/jvh.12553 doi


Aged
Aged, 80 and over
Antiviral Agents--administration & dosage
Carbamates
Drug-Related Side Effects and Adverse Reactions--epidemiology
Female
Hepatitis C, Chronic--drug therapy
Humans
Imidazoles--administration & dosage
Incidence
Isoquinolines--administration & dosage
Male
Middle Aged
Pilot Projects
Prospective Studies
Pyrrolidines
Renal Dialysis
Renal Insufficiency--complications
Sulfonamides--administration & dosage
Sustained Virologic Response
Treatment Outcome
Valine--analogs & derivatives